GENETIC VECTORS INC
SB-2, EX-5.1, 2000-08-24
PHARMACEUTICAL PREPARATIONS
Previous: GENETIC VECTORS INC, SB-2, EX-1.5, 2000-08-24
Next: GENETIC VECTORS INC, SB-2, EX-21, 2000-08-24




Kirkpatrick & Lockhart LLP                            Miami Center
                                                      201 South Biscayne Blvd.
                                                      Miami, Florida  33131-2399
                                                      305.539.3300
                                                      www.kl.com


August ___, 2000

Genetic Vectors, Inc.
5201 N.W. 77th Avenue, Suite 100
Miami, Florida 33166

RE:   GENETIC VECTORS, INC. (THE "CORPORATION")
      REGISTRATION STATEMENT ON FORM SB-2 (THE "REGISTRATION STATEMENT")
                                                ----------------------

Gentlemen:

We have acted as counsel to the  Corporation in connection  with the preparation
of the Registration  Statement filed with the Securities and Exchange Commission
pursuant to the Securities Act of 1933, as amended (the "1933 ACT"), relating to
the  proposed  public  offering of up to 1,610,000  shares of the  Corporation's
Common  Stock,  par value $0.01 per share (the "COMMON  STOCK"),  including  the
over-allotment option referenced therein.

We are  furnishing  this  opinion to you in  accordance  with Item  601(b)(5) of
Regulation S-B  promulgated  under the 1933 Act for filing as Exhibit 5.1 to the
Registration Statement.

We are  familiar  with the  Registration  Statement,  and we have  examined  the
Corporation's  Articles of Incorporation,  as amended to date, the Corporation's
Bylaws,  as amended to date, and minutes and  resolutions  of the  Corporation's
Board of Directors and shareholders. We have also examined such other documents,
certificates,  instruments and corporate records,  and such statutes,  decisions
and questions of law as we have deemed  necessary or appropriate for the purpose
of this opinion.

Based upon the foregoing,  we are of the opinion that the shares of Common Stock
to be sold by the Corporation to the public,  when issued and sold in the manner
described in the  Registration  Statement (as amended),  will be validly issued,
fully paid and non-assessable.

We  hereby  consent  to  the  filing  of  this  opinion  as an  Exhibit  to  the
Registration Statement and to the use of our name in the Prospectus constituting
a part  thereof in  connection  with the  matters  referred to under the caption
"Legal Matters."

Very truly yours,

KIRKPATRICK & LOCKHART LLP




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission